Latest Conference Articles

Heather Yun, MD, IDWeek 2023 Chair, Says Emerging Threats May be Bigger than Pathogens

Heather Yun, MD, IDWeek 2023 Chair, Says Emerging Threats May be Bigger than Pathogens

October 16th 2023

IDWeek

IDWeek 2023 chair Yun points to climate change and other human-driven devastation of the biosphere as the global threats that will cause disease at local levels.

IDWeek 2023: Nirsevimab Efficacy Against RSV-LRTI-Associated Hospitalization is Robust Across Infant Subgroups

IDWeek 2023: Nirsevimab Efficacy Against RSV-LRTI-Associated Hospitalization is Robust Across Infant Subgroups

October 15th 2023

IDWeek

IDWeek 2023. Nirsevimab efficacy was significant across infant subgroups in preventing hospitalization for RSV-LRTI during a first RSV season.

IDWeek 2023: New Data Provide Closer Look at Real-World Utilization of Cabotegravir for HIV PrEP

IDWeek 2023: New Data Provide Closer Look at Real-World Utilization of Cabotegravir for HIV PrEP

October 15th 2023

IDWeek

IDWeek 2023. New study found just slightly more than half of prescriptions for cabotegravir for HIV PrEP resulted in at least 1 injection, suggesting limitations in use and access to the injectable HIV integrase inhibitor.

In People Living with HIV, Switch from Oral ART to Long-Acting Injectable Significantly Improved Adherence, Persistence

In People Living with HIV, Switch from Oral ART to Long-Acting Injectable Significantly Improved Adherence, Persistence

October 11th 2023

IDWeek

IDWeek 2023: In a large cohort of people living with HIV, those switching from oral ART to long acting CAB+RPV were more than 4x as likely to adhere to the regimen.

Adolescents Prefer Combination Meningococcal Vaccine to Separate MenACWY and MenB Administration a New Study Finds

Adolescents Prefer Combination Meningococcal Vaccine to Separate MenACWY and MenB Administration a New Study Finds

October 11th 2023

IDWeek

IDWeek 2023: Adolescents expressed a preference for a combination vaccine covering serogroups A, B, C, W, Y of invasive meningococcal disease, reported researchers.

US Meningococcal Vaccination Coverage Has Increased, but Disparities Persist, According to Data Presented at IDWeek 2023

US Meningococcal Vaccination Coverage Has Increased, but Disparities Persist, According to Data Presented at IDWeek 2023

October 11th 2023

IDWeek

Findings underscore the persistence of disparities in meningococcal vaccination coverage in the US, particularly for vaccination against serogroup B.

IDWeek 2023 Features Leaders Spanning the Specialty's Expertise

IDWeek 2023 Features Leaders Spanning the Specialty's Expertise

October 10th 2023

IDWeek

IDWeek 2023: Leading physician scientists will headline plenary sessions and named lectureships on topics ranging from antibiotic stewardship to artificial intelligence.

IDWeek 2023, October 11-15: Preview of Topics and Presentations

IDWeek 2023, October 11-15: Preview of Topics and Presentations

October 9th 2023

IDWeek

IDWeek 2023: Imagine an intriguing hot topic in infectious disease and you'll find a session or 2 where you can learn more and then choose the next topic, rinse, and repeat.

Glycemic Screening in Childhood May Predict Diabetes-Related Complications, According to New Data

Glycemic Screening in Childhood May Predict Diabetes-Related Complications, According to New Data

June 29th 2023

ADA

ADA 2023: Findings from a new study show that higher levels of glycemia in childhood are associated with future microvascular complications, such as nephropathy and retinopathy.

New Data Suggest Higher Doses of Oral Semaglutide Beneficial for Management of Type 2 Diabetes

New Data Suggest Higher Doses of Oral Semaglutide Beneficial for Management of Type 2 Diabetes

June 27th 2023

ADA

ADA 2023. Results from PIONEER PLUS trial showed oral semaglutide 25 mg and 50 mg were superior than 14 mg in reducing HbA1c and body weight in adults with T2D.